longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SCTX

SCTX
----

LongbridgeAI

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga_article
Jul 30, 2026 at 09:05 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Several healthcare stocks moved significantly in Thursday's after-market session, largely driven by Q2 earnings reports. Gainers included Scribe Therapeutics (+12.7%), uniQure (+9.5%), Guardant Health (+8.3%), CareDx (+7.6%), Castle Biosciences (+7.6%), and Healthcare Triangle (+7.4%). Conversely, major losers were Karyopharm Therapeutics (-59.1%), Myriad Genetics (-30.6%), Nuwellis (-29.0%), Fulgent Genetics (-16.9%), Alignment Healthcare (-14.3%), and Cerus (-13.9%).

Gainers

  • Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's after-market session. The market value of their outstanding shares is at $297.1 million.
  • uniQure (NASDAQ:QURE) shares increased by 9.5% to $46.2. The company's market cap stands at $2.7 billion. As per the press release, Q2 earnings came out yesterday.
  • Guardant Health (NASDAQ:GH) shares moved upwards by 8.3% to $165.0. The market value of their outstanding shares is at $19.1 billion. As per the press release, Q2 earnings came out today.
  • CareDx (NASDAQ:CDNA) shares increased by 7.61% to $41.0. The company's market cap stands at $1.8 billion. The company's, Q2 earnings came out today.
  • Castle Biosciences (NASDAQ:CSTL) shares moved upwards by 7.61% to $28.83. The company's market cap stands at $741.0 million. As per the news, the Q2 earnings report came out today.
  • Healthcare Triangle (NASDAQ:HCTI) shares moved upwards by 7.42% to $1.23. The company's market cap stands at $3.1 million.

Losers

  • Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 59.1% to $2.87 during Thursday's after-market session. The company's market cap stands at $155.4 million.
  • Myriad Genetics (NASDAQ:MYGN) shares fell 30.57% to $3.73. The market value of their outstanding shares is at $476.0 million. As per the press release, Q2 earnings came out today.
  • Nuwellis (NASDAQ:NUWE) shares decreased by 28.98% to $3.16.
  • Fulgent Genetics (NASDAQ:FLGT) shares decreased by 16.87% to $16.8. The market value of their outstanding shares is at $607.1 million. As per the news, the Q2 earnings report came out today.
  • Alignment Healthcare (NASDAQ:ALHC) stock decreased by 14.3% to $15.95. The company's market cap stands at $3.7 billion. The company's, Q2 earnings came out today.
  • Cerus (NASDAQ:CERS) stock decreased by 13.85% to $2.49. The market value of their outstanding shares is at $575.0 million. As per the press release, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Login to unlock1,587characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Nuwellis

Nuwellis

USNUWE

+2.89%

Uniqure

Uniqure

USQURE

+0.94%

Karyopharm Therap

Karyopharm Therap

USKPTI

-0.62%